324 related articles for article (PubMed ID: 12424102)
1. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.
Miyazaki Y; Glass L; Triplitt C; Wajcberg E; Mandarino LJ; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1135-43. PubMed ID: 12424102
[TBL] [Abstract][Full Text] [Related]
2. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.
Miyazaki Y; DeFronzo RA
Cardiovasc Diabetol; 2009 Aug; 8():44. PubMed ID: 19656356
[TBL] [Abstract][Full Text] [Related]
3. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
4. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
5. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
[TBL] [Abstract][Full Text] [Related]
6. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of visceral fat accumulation in type 2 diabetes.
Gastaldelli A; Miyazaki Y; Pettiti M; Matsuda M; Mahankali S; Santini E; DeFronzo RA; Ferrannini E
J Clin Endocrinol Metab; 2002 Nov; 87(11):5098-103. PubMed ID: 12414878
[TBL] [Abstract][Full Text] [Related]
8. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.
Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
Clin Sci (Lond); 2017 Aug; 131(15):1905-1917. PubMed ID: 28620012
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.
Goodpaster BH; Thaete FL; Simoneau JA; Kelley DE
Diabetes; 1997 Oct; 46(10):1579-85. PubMed ID: 9313753
[TBL] [Abstract][Full Text] [Related]
10. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.
Barzilai N; Banerjee S; Hawkins M; Chen W; Rossetti L
J Clin Invest; 1998 Apr; 101(7):1353-61. PubMed ID: 9525977
[TBL] [Abstract][Full Text] [Related]
11. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Bajaj M; Suraamornkul S; Piper P; Hardies LJ; Glass L; Cersosimo E; Pratipanawatr T; Miyazaki Y; DeFronzo RA
J Clin Endocrinol Metab; 2004 Jan; 89(1):200-6. PubMed ID: 14715850
[TBL] [Abstract][Full Text] [Related]
12. Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.
Cree-Green M; Wiromrat P; Stuppy JJ; Thurston J; Bergman BC; Baumgartner AD; Bacon S; Scherzinger A; Pyle L; Nadeau KJ
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E186-E195. PubMed ID: 30562061
[TBL] [Abstract][Full Text] [Related]
13. Resistance training enhances insulin suppression of endogenous glucose production in elderly women.
Honka MJ; Bucci M; Andersson J; Huovinen V; Guzzardi MA; Sandboge S; Savisto N; Salonen MK; Badeau RM; Parkkola R; Kullberg J; Iozzo P; Eriksson JG; Nuutila P
J Appl Physiol (1985); 2016 Mar; 120(6):633-9. PubMed ID: 26744506
[TBL] [Abstract][Full Text] [Related]
14. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses.
Juurinen L; Kotronen A; Granér M; Yki-Järvinen H
J Clin Endocrinol Metab; 2008 Jan; 93(1):118-24. PubMed ID: 17956948
[TBL] [Abstract][Full Text] [Related]
16. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
Llauradó G; Sevastianova K; Sädevirta S; Hakkarainen A; Lundbom N; Orho-Melander M; Groop PH; Forsblom C; Yki-Järvinen H
J Clin Endocrinol Metab; 2015 Feb; 100(2):607-16. PubMed ID: 25405502
[TBL] [Abstract][Full Text] [Related]
17. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
18. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.
Banerji MA; Buckley MC; Chaiken RL; Gordon D; Lebovitz HE; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):846-50. PubMed ID: 8963350
[TBL] [Abstract][Full Text] [Related]
19. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins.
Pietiläinen KH; Rissanen A; Kaprio J; Mäkimattila S; Häkkinen AM; Westerbacka J; Sutinen J; Vehkavaara S; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E768-74. PubMed ID: 15585588
[TBL] [Abstract][Full Text] [Related]
20. Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients.
Nyholm B; Nielsen MF; Kristensen K; Nielsen S; Østergård T; Pedersen SB; Christiansen T; Richelsen B; Jensen MD; Schmitz O
Eur J Endocrinol; 2004 Feb; 150(2):207-14. PubMed ID: 14763919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
